| Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome V Pengo, G Denas, G Zoppellaro, SP Jose, A Hoxha, A Ruffatti, L Andreoli, ... Blood, The Journal of the American Society of Hematology 132 (13), 1365-1371, 2018 | 725 | 2018 |
| Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome V Pengo, A Ruffatti, C Legnani, P Gresele, D Barcellona, N Erba, S Testa, ... Journal of thrombosis and haemostasis 8 (2), 237-242, 2010 | 705 | 2010 |
| Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samples V Pengo, A Biasiolo, P Gresele, F MARONGIU, N Erba, F Veschi, ... Journal of thrombosis and Haemostasis 5 (5), 925-930, 2007 | 129 | 2007 |
| Pulmonary thrombosis in 2019‐nCoV pneumonia? F Marongiu, E Grandone, D Barcellona Journal of Thrombosis and Haemostasis 18 (6), 1511-1513, 2020 | 123 | 2020 |
| Patient education and oral anticoagulant therapy D Barcellona, P Contu, F Marongiu Haematologica 87 (10), 1081-1086, 2002 | 118 | 2002 |
| Warfarin or acenocoumarol: which is better in the management of oral anticoagulants? D Barcellona, ML Vannini, L Fenu, C Balestrieri, F Marongiu Thrombosis and haemostasis 80 (12), 899-902, 1998 | 115 | 1998 |
| The management of oral anticoagulant therapy: the patient’s point of view D Barcellona, P Contu, GG Sorano, V Pengo, F Marongiu Thrombosis and haemostasis 83 (01), 49-53, 2000 | 99 | 2000 |
| Point-of-care testing INR: an overview D Barcellona, L Fenu, F Marongiu Clinical Chemistry and Laboratory Medicine (CCLM) 55 (6), 800-805, 2017 | 65 | 2017 |
| Pulmonary thrombosis: a clinical pathological entity distinct from pulmonary embolism? F Marongiu, A Mameli, E Grandone, D Barcellona Seminars in Thrombosis and Hemostasis 45 (08), 778-783, 2019 | 64 | 2019 |
| The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation E Antonucci, D Poli, A Tosetto, V Pengo, A Tripodi, N Magrini, F Marongiu, ... PLoS ONE 10 (5), e0124719, 2015 | 61 | 2015 |
| Trial of rivaroxaban in antiPhospholipid syndrome (TRAPS): two‐year outcomes after the study closure V Pengo, A Hoxha, L Andreoli, A Tincani, E Silvestri, D Prisco, T Fierro, ... Journal of thrombosis and haemostasis 19 (2), 531-535, 2021 | 59 | 2021 |
| A Comparison of Lupus Anticoagulant–Positive Patients With Clinical Picture of Antiphospholipid Syndrome and Those Without V Pengo, A Biasiolo, P Gresele, F Marongiu, N Erba, F Veschi, ... Arteriosclerosis, Thrombosis, and Vascular Biology 27 (12), e309-e310, 2007 | 58 | 2007 |
| Rheumatoid arthritis and thrombosis A Mameli, D Barcellona, F Marongiu Clin Exp Rheumatol 27, 846-855, 2009 | 57 | 2009 |
| Mechanical prosthetic heart valves: Quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study D Poli, E Antonucci, V Pengo, L Migliaccio, S Testa, C Lodigiani, N Coffetti, ... International journal of cardiology 267, 68-73, 2018 | 55 | 2018 |
| The management of acute venousthromboembolism in clinical practice–study rationale and protocol of theEuropean PREFER in VTE Registry G Agnelli, AK Gitt, B Rupert, F Eva-Maria, L Petra, M Patrick, M Manuel, ... Thrombosis Journal 13, 41, 2015 | 53 | 2015 |
| Allele 4G of gene PAI-1 associated with prothrombin mutation G20210A increases the risk for venous thrombosis D Barcellona, L Fenu, C Cauli, G Pisu, F Marongiu Thrombosis and haemostasis 90 (12), 1061-1064, 2003 | 52 | 2003 |
| Molecular pathways triggered by COVID-19 in different organs: ACE2 receptor-expressing cells under attack? A review L Saba, C Gerosa, D Fanni, F Marongiu, G LA NASA, G Caocci, ... European Review for Medical and Pharmacological Sciences 24 (23), 12609-12622, 2020 | 51 | 2020 |
| The predictive ability of bleeding risk stratification models in very old patients on vitaminK antagonist treatment for venous thromboembolism: results of the prospective … D Poli, E Antonucci, S Testa, B Cosmi, G Palareti, W Ageno, ... JOURNAL OF THROMBOSIS AND HAEMOSTASIS 11 (6), 1053-1058, 2013 | 46 | 2013 |
| Vaccine-induced severe thrombotic thrombocytopenia following COVID-19 vaccination: A report of an autoptic case and review of the literature D Fanni, L Saba, R Demontis, C Gerosa, A Chighine, M Nioi, JS Suri, ... European Review for Medical and Pharmacological Sciences 25 (15), 5063-5069, 2021 | 42 | 2021 |
| Point-of-care (POCT) prothrombin time monitors: is a periodical control of their performance useful? D Barcellona, L Fenu, S Cornacchini, F Marongiu Thrombosis research 123 (5), 775-779, 2009 | 39 | 2009 |
Francesco MarongiuUniversità di CagliariVerified email at medicina.unica.it
